Ernst J Verschoor
Overview
Explore the profile of Ernst J Verschoor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
1103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boszormenyi K, Stammes M, Fagrouch Z, Acar F, Niphuis H, Kayere G, et al.
Front Cell Infect Microbiol
. 2025 Jan;
14:1505720.
PMID: 39744155
Infection of an adult rhesus macaque with SARS-CoV-2 led to viral RNAemia in nose, throat, and lungs. The animal also presented extended fecal shedding of viral genomic and subgenomic messenger...
2.
Reguzova A, Muller M, Pagallies F, Burri D, Salomon F, Rziha H, et al.
NPJ Vaccines
. 2024 Oct;
9(1):191.
PMID: 39414789
Among the common strategies to design next-generation COVID-19 vaccines is broadening the antigenic repertoire thereby aiming to increase efficacy against emerging variants of concern (VoC). This study describes a new...
3.
Koopman G, Verhoeven T, Mooij P, Acar R, Harmand T, Flanagan L, et al.
J Med Virol
. 2024 Oct;
96(10):e29956.
PMID: 39400953
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) impacts multiple anatomical sites. Whether this is due to the virus itself or is a secondary effect caused by the influx...
4.
Mooij P, Mortier D, Aartse A, Murad A, Correia R, Roldao A, et al.
Front Immunol
. 2023 Sep;
14:1256094.
PMID: 37691927
The first exposure to influenza is presumed to shape the B-cell antibody repertoire, leading to preferential enhancement of the initially formed responses during subsequent exposure to viral variants. Here, we...
5.
Nieuwland J, Nutma E, Philippens I, Boszormenyi K, Remarque E, Bakker J, et al.
J Neuroinflammation
. 2023 Jul;
20(1):179.
PMID: 37516868
Background: Coronavirus disease 2019 (COVID-19) patients initially develop respiratory symptoms, but they may also suffer from neurological symptoms. People with long-lasting effects after acute infections with severe respiratory syndrome coronavirus...
6.
Koopman G, Amacker M, Stegmann T, Verschoor E, Verstrepen B, Bhoelan F, et al.
Sci Rep
. 2023 Mar;
13(1):5074.
PMID: 36977691
Influenza virosomes serve as antigen delivery vehicles and pre-existing immunity toward influenza improves the immune responses toward antigens. Here, vaccine efficacy was evaluated in non-human primates with a COVID-19 virosome-based...
7.
Goethals O, Kaptein S, Kesteleyn B, Bonfanti J, Van Wesenbeeck L, Bardiot D, et al.
Nature
. 2023 Mar;
615(7953):678-686.
PMID: 36922586
Dengue is a major health threat and the number of symptomatic infections caused by the four dengue serotypes is estimated to be 96 million with annually around 10,000 deaths. However,...
8.
Meijer L, Boszormenyi K, Bakker J, Koopman G, Mooij P, Verel D, et al.
Nucl Med Biol
. 2022 Jun;
112-113:1-8.
PMID: 35660200
Rationale: The aim of this study was to investigate the application of [F]DPA714 to visualize the inflammation process in the lungs of SARS-CoV-2-infected rhesus monkeys, focusing on the presence of...
9.
Wichgers Schreur P, Mooij P, Koopman G, Verstrepen B, Fagrouch Z, Mortier D, et al.
NPJ Vaccines
. 2022 May;
7(1):54.
PMID: 35585071
Rift Valley fever virus (RVFV) is an emerging mosquito-borne bunyavirus that is highly pathogenic to wild and domesticated ruminants, camelids, and humans. While animals are exclusively infected via mosquito bites,...
10.
Volkmann A, Koopman G, Mooij P, Verschoor E, Verstrepen B, Bogers W, et al.
Front Immunol
. 2022 Apr;
13:857440.
PMID: 35479095
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide pandemic. Here, we present non-human primate immunogenicity and protective efficacy data generated with the capsid virus-like particle (cVLP)-based vaccine...